Detalhe da pesquisa
1.
Enhanced axillary assessment using intradermally injected microbubbles and contrast-enhanced ultrasound (CEUS) before neoadjuvant systemic therapy (NACT) identifies axillary disease missed by conventional B-mode ultrasound that may be clinically relevant.
Breast Cancer Res Treat
; 185(2): 413-422, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33029707
2.
Phase 2 study of anastrozole in recurrent estrogen (ER)/progesterone (PR) positive endometrial cancer: The PARAGON trial - ANZGOG 0903.
Gynecol Oncol
; 154(1): 29-37, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31130288
3.
Fulvestrant plus anastrozole or placebo versus exemestane alone after progression on non-steroidal aromatase inhibitors in postmenopausal patients with hormone-receptor-positive locally advanced or metastatic breast cancer (SoFEA): a composite, multicentre, phase 3 randomised trial.
Lancet Oncol
; 14(10): 989-98, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23902874
4.
A Nationwide Survey of UK Oncologists' Views on the Choice of Radiotherapy Regime for the Reconstructed Chest Wall in Breast Cancer Patients.
Int J Breast Cancer
; 2017: 6385432, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28116166
5.
Technique and outcome of post-mastectomy adjuvant chest wall radiotherapy-the role of tissue-equivalent bolus in reducing risk of local recurrence.
Br J Radiol
; 89(1064): 20160060, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-27251295
6.
Osteonecrosis of the jaw and oral health-related quality of life after adjuvant zoledronic acid: an adjuvant zoledronic acid to reduce recurrence trial subprotocol (BIG01/04).
J Clin Oncol
; 31(21): 2685-91, 2013 Jul 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-23796998